Patient and Caregiver Resources on Teplizumab Treatment for Type 1 Diabetes (T1D)

The information contained in this portal is designed to assist the caregivers and patients who have been identified and confirmed as being eligible to receive teplizumab.

We invite you to explore the different sections, as well as resources and high definition animations, which contain information on how to prepare and what to expect before, during, and after treatment.

This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Sanofi US.
Copyright © 2025 | Med Learning Group | All Rights Reserved | Website by Divigner

Pin It on Pinterest

Directory
Scroll to Top

You are leaving the DETECT-T1D website

To access the NICA Infusion Center Locator, a trademark is used. Tzield® is teplizumab.

For optimized Clinical Trial Tracker use, please utilize Chrome or Firefox browsers